Section 1: Diagnosis 1. Risk factors for pancreatic cancer 2. Familiar risk factors and genetic testing for inherited mutation 3. Screening/surveillance in high-risk population to detect pancreatic cancer 4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer 5. CT for diagnosis and staging of pancreatic cancer 6. MRI/MRCP for diagnosis and staging of pancreatic cancer 7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer 8.
Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer 9. PET/CT for diagnosis, staging and follow-up 10. Staging laparoscopy and laparoscopic ultrasound 11. Germline and tumor/somatic genomic testing 12. Staging for pancreatic cancer Section 2: Treatments for resectable and borderline resectable pancreatic cancer 13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer 14. Surgical resection for pancreatic cancer 15. Minimally invasive pancreatic surgery for pancreatic cancer 16.
Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer 17. Follow-up surveillance and management for patients after pancreatic surgery Section 3: Treatments for locally advanced and metastatic pancreatic cancer 18. Treatment strategies for locally advanced pancreatic cancer 19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy 20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer 21. Second-line chemotherapy for advanced pancreatic cancer 22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancer Section 4: Supportive and Palliative medicine for pancreatic cancer 23. Stents for obstructive jaundice and gastric outlet obstruction 24.
Palliative surgery in advanced pancreatic cancer 25. Pain control 26. Managements for anxiety and depression 27. Advance care planning for pancreatic cancer patients 28. Venous thromboembolism in patients with pancreatic cancer 29. Managements for ascites.